APA (7th ed.) Citation

Y, R., S, M., EY, Y., Y, C., R, v. A., AH, A., . . . A, W. (2026). Antidiabetic Medications and Bladder Cancer Risk in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 32(3), 442. https://doi.org/10.1016/j.eprac.2025.11.017

Chicago Style (17th ed.) Citation

Y, Rao, Meng S, Yu EY, Chen Y, van Alebeek R, Al-Zalabani AH, Zeegers MP, and Wesselius A. "Antidiabetic Medications and Bladder Cancer Risk in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials." Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 32, no. 3 (2026): 442. https://doi.org/10.1016/j.eprac.2025.11.017.

MLA (9th ed.) Citation

Y, Rao, et al. "Antidiabetic Medications and Bladder Cancer Risk in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials." Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, vol. 32, no. 3, 2026, p. 442, https://doi.org/10.1016/j.eprac.2025.11.017.